Identification of the promoter, genomic structure, and mouse ortholog of LGI1

Citation
Rpt. Somerville et al., Identification of the promoter, genomic structure, and mouse ortholog of LGI1, MAMM GENOME, 11(8), 2000, pp. 622-627
Citations number
43
Categorie Soggetti
Molecular Biology & Genetics
Journal title
MAMMALIAN GENOME
ISSN journal
09388990 → ACNP
Volume
11
Issue
8
Year of publication
2000
Pages
622 - 627
Database
ISI
SICI code
0938-8990(200008)11:8<622:IOTPGS>2.0.ZU;2-C
Abstract
The human LGI1 gene is a leucine-rich, repeat-containing gene that was clon ed from the t(10:19) breakpoint of the T98G glioblastoma cell line. The LGI 1 gene maps to 10q24, a region of peak LOH in malignant gliomas, and is ina ctivated during the transition from low to high-grade brain tumors. Here we report detailed studies of the genomic structure of the LGI1 gene and its promoter. We have also cloned and characterized the mouse lgil gene, which is 97% homologous to the human gene at the amino acid level and 91% homolog ous at the nucleotide level. LGI1 contains 8 exons, when each of the four l eucine-rich repeat units is contained in an individual 72-bp exon. The cyst eine-rich regions flanking the LRR and the single trans-membrane domain do not occupy individual exons. Approximately 5-kb of the genomic region 5' to LGI1 was sequenced, but conventional CAAT and TATA motifs were not present within this sequence. A 597-bp fragment of this 5' sequence was cloned ups tream of a promoterless luciferase gene and was shown to be sufficient to d rive transcription. SSCP analysis of the coding region of LGI1 in 20 gliobl astomas and five cell lines did not reveal any mutations. Because LGI1 expr ession is considerably downregulated in gliomas, we also investigated wheth er this was owing to changes in the methylation status of the promoter. Sou thern blot analysis and 5-azacytidine treatment did not show any appreciabl e difference in methylation status between normal brain and glioblastomas.